Sort
82,697 grants matching “vaccine development”
Shigella Live Vector-Based Multivalent Vaccine
$925,332Eileen M. Barry · University Of Maryland Baltimore · U19 · FY2017 · AI
Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine.
$925,300Nhi Khuong · Lumen Bioscience, Inc. · R42 · FY2024 · AI
NHP MHC COMPLEX ALLELE DISCOVERY AND TYPING TECHNOLOGY DEVELOPMENT - HIV/AIDS
$925,074Daniel Geraghty · Fred Hutchinson Cancer Research Center · N01 · FY2017 · AI
Collaborative Research: Ideas Lab: The Role of Extracellular RNA in Intercellular and Interkingdom Communication
$924,987Corbin D Jones · University Of North Carolina At Chapel Hill · · FY2023 · BIO
Immunity to novel T/F SHIVs: variability in the co-evolution of virus and host immunity
$924,975Garnett H Kelsoe · Duke University · R01 · FY2020 · AI
Genomic Studies of the Impact of External Factors on Parasite Development and Disease Outcome
$924,968Joana Carneiro Da Silva · University Of Maryland Baltimore · U19 · FY2021 · AI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls
$924,957Angela Diaz · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AI
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
$924,949Scott C Weaver · University Of Texas Med Br Galveston · R24 · FY2017 · AI
Shigella Live Vector-Based Multivalent Vaccine
$924,842Eileen M. Barry · University Of Maryland Baltimore · U19 · FY2018 · AI
INTRAVESICAL ONCOLYTIC THERAPY FOR BLADDER CANCER
$924,838Rosa Maria Diaz · Vyriad, Inc. · R44 · FY2018 · CA
Investigation of a nanoparticle albumin-bound mTOR inhibitor, nab-rapamycin for t
$924,745Neil Desai · Aadi, Llc · R42 · FY2015 · CA
Vaccines Designed From Analysis of Recent HIV Infections
$924,689Vaxgen, Inc. · R44 · FY2004 · AI
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$924,682Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Design and optimization of DL-NLTs and molecular adjuvants to increase potency and promote NAb formation in vivo
$924,582David B. Weiner · Wistar Institute · U19 · FY2025 · AI
Global HIV/AIDS Vaccine Enterprise
$924,240Kevin Osborne · National Institute Of Allergy And Infectious Diseases · Y01 · FY2020 · AI
HIV-1 Genetic Variation in Infected Individuals
$924,183Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
NLM's Personal Health Record and Consumer Service R&D
$924,076Clement McDonald · National Library Of Medicine · ZIA · FY2011 · LM
Hunting the HIV-1 Unicorn
$923,998Sara Sawyer · University Of Colorado · DP1 · FY2020 · DA
Hunting the HIV-1 Unicorn
$923,998Sara Sawyer · University Of Colorado · DP1 · FY2022 · DA
Hunting the HIV-1 Unicorn
$923,998Sara Sawyer · University Of Colorado · DP1 · FY2021 · DA
Signal Transduction Events and the Regulation of Cell Growth
$923,994Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2019 · CA
Harvard Medical School Vaccine Clinical Trials Unit
$923,972Raphael Dolin · Beth Israel Deaconess Medical Center · U01 · FY2010 · AI
HIV-1 Fusion Peptide-directed Vaccine Design Using Virus-like Particles
$923,921Rui Kong · Emory University · R01 · FY2021 · AI
ADOLESCENT MEDICINE TRIAL NETWORK FOR HIV/AIDS
$923,892Westat, Inc. · U01 · FY2001 · HD
T CELL MEMORY GENERATION AND FUNCTION
$923,730Trudeau Institute, Inc. · P01 · FY2000 · AI